Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950123-10-013246
Filing Date
2010-02-16
Accepted
2010-02-16 16:10:12
Documents
2
Group Members
VENROCK ASSOCIATES III, L.P.VENROCK ENTERPRENEURS FUND III, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A w77386dsc13gza.htm SC 13G/A 57012
2 EX-99.A w77386dexv99wa.htm EX-99.A 3788
  Complete submission text file 0000950123-10-013246.txt   63007
Mailing Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112
Business Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112 2126495600
VENROCK ASSOCIATES (Filed by) CIK: 0000937889 (see all company filings)

EIN.: 136300995 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Subject) CIK: 0001113148 (see all company filings)

EIN.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60943 | Film No.: 10607788
SIC: 2834 Pharmaceutical Preparations